Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;18(10):1757.
doi: 10.1513/AnnalsATS.202104-516LE.

Reply: Adoption of Antifibrotic Medications: A Closer Look at the Data

Affiliations
Comment

Reply: Adoption of Antifibrotic Medications: A Closer Look at the Data

Timothy M Dempsey et al. Ann Am Thorac Soc. 2021 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH. Adoption of the anti-fibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2021 - PubMed
    1. Salisbury ML, Conoscenti CS, Culver DA, Yow E, Neely ML, Bender S, et al. Antifibrotic drug use in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Ann Am Thorac Soc. 2020;17:1413–1423. - PMC - PubMed
    1. Holtze CH, Freiheit EA, Limb SL, Stauffer JL, Raimundo K, Pan WT, et al. Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry. Respir Res. 2020;21:48. - PMC - PubMed
    1. Choudhry NK, Lee JL, Agnew-Blais J, Corcoran C, Shrank WH. Drug company-sponsored patient assistance programs: a viable safety net? Health Aff (Millwood) 2009;28:827–834. - PMC - PubMed

LinkOut - more resources